Excessive Sweating Clinical Trials

A listing of Excessive Sweating medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 12 clinical trials
Featured trial
A 10-week study to evaluate a topical treatment for excessive underarm sweating.

A 10-week study to evaluate a topical treatment for excessive underarm sweating.

  • 1877 views
  • 25 Mar, 2021
  • 1 location
Compensatory Sweating After Unilateral Sympathectomy on the Dominant Side or Bilateral Sequential Sympathectomy (Universusbi)

The standard treatment for palmar hyperhidrosis is bilateral sequential thoracic sympathectomy. High rates of compensatory sweating due to the surgical procedure are described in the literature

Accepts healthy volunteers
  • 222 views
  • 03 Feb, 2022
  • 7 locations
Qbrexza Cloths for Hyperhidrosis of Amputation Sites

This is a Prospective, Double Blinded, Placebo Controlled, Randomized, Cross-over trial using Qbrexza Cloths to treat hyperhidrosis of amputation sites. There is a 2 week screening period where

limb amputation
  • 5 views
  • 23 Mar, 2022
  • 1 location
Reducing Cannabis Overuse With Prazosin (ReCOUP)

reduce or stop cannabis use may experience cannabis withdrawal symptoms including insomnia and distressing dreams, anxiety, irritability, and/or excessive sweating that they may misattribute to re

cannabis use
insomnia
anxiety
nightmares
prazosin
  • 0 views
  • 16 Jun, 2022
  • 1 location
Injections of Botulinic Toxin in Plantar Lesions of Localized Epidermolysis Bullosa Simplex (EBTox)

The investigators hypothesize that palmar injections of botulinic toxin, via an inhibition of the sudation, would limit the occurrence of blisters in localized epidermolysis bullosa simplex (LEBS).

epidermolysis bullosa simplex
anesthesia
  • 186 views
  • 27 Feb, 2022
  • 3 locations
Investigation of the Persistence of SARS-CoV-2 in the Olfactory Mucosa of Patients With Prolonged Symptoms of COVID-19 (NEUROCOVID)

NEUROCOVID is a prospective multicenter study comparing the proportion of patients with SARS-CoV-2 viral RNA at the level of the olfactory clefts in a group of cases compared to a group of controls as well as the correlations between the virological and cellular abnormalities observed in the olfactory mucosa and …

  • 0 views
  • 04 Oct, 2022
  • 1 location
Adrenergic Blockers for Cardiac Changes in Early Parkinson's Disease (Protocol 53136)

REM Behavior Sleep Disorder (RBD) is a sleep disorder causing people to 'act out' their dreams. A high percentage of individuals with idiopathic RBD (iRBD) are known to develop conditions affecting the neurons in the brain such as Parkinson's disease (PD). Based on the increased risk to develop PD, individuals …

antidepressants
depression
dopamine
sleep disorder
early parkinson's
  • 64 views
  • 07 Oct, 2022
  • 1 location
Surgical Pre-habilitation in Breast Cancer.

The National Cancer Institute estimated 625 thousand new cases of cancer (excluding cases of non-melanoma skin cancer) in Brazil for each year between 2020-2022. In 2018, there were 2.1 million new cases of breast cancer in the world, being the first in the ranking of cancers in women. Practices in …

  • 0 views
  • 14 Jul, 2022
  • 1 location
Botulinum Toxin Therapy in Hidradenitis Suppurativa (HS)

This mechanistic observational study will build on data from humans implicating TRPV1 nociceptors in the pathogenesis of the Type-17 chronic inflammatory skin disease Hidradenitis Suppurativa (HS). In this study, the investigators will test the hypothesis that inhibiting neuropeptide activity with botulinum toxin reduces pathogenic IL-17 inflammation, relieves pain, and improves …

il-17
  • 0 views
  • 04 Oct, 2022
  • 1 location
Neuroinflammation in Chronic Systemic Symptoms (CSS)

The purpose of the present research protocol is to investigate and identify translocator protein 18kDa, MRI DTI, and EEG/ERPs, markers of Chronic Systemic Symptoms (CSS).

  • 0 views
  • 19 Sep, 2021
  • 1 location